止吐药和促动力药_2015V1.PPT

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
止吐药和促动力药_2015V1

3. Laxatives that decrease absorption Liquid petrolatum ( Lubricate the fecal mass, prevent excessive dehydration of the material , and may inhibit water reabsorption by coating the gut wall) Modulators of gastrointestinal functions Proton pump inhibitors are administered as inactive prodrugs. Within the acidified compartment the prodrug rapidly becomes protonated and is concentrated 1000-fold within the parietal cell canaliculus. There, it rapidly undergoes a molecular conversion to the active, reactive thiophilic sulfonamide cation. The sulfonamide reacts with the H+/K+ ATPase, forms a covalent disulfide linkage, and irreversibly inactivates the enzyme 影响药物分布 ?药物的理化性质; ?局部的血流量; ?体液的pH值; ?生物屏障(血脑屏障、胎盘屏障)等。 影响药物分布 ?药物的理化性质; ?局部的血流量; ?体液的pH值; ?生物屏障(血脑屏障、胎盘屏障)等。 Misoprostol has both acid inhibitory and mucosal protective properties. it binds to a prostaglandin receptor on parietal cells, reducing histamine-stimulated cAMP production and causing modest acid inhibition Peptic ulcers develop in approximately 10–20% of patients who receive long-term NSAID therapy Diarrhea and cramping abdominal pain occurs in 10–20% of patients. misoprostol stimulates uterine contractions ( Sucralfate is a salt of sucrose complexed to sulfated aluminum hydroxide. the negatively charged sucrose sulfate binds to positively charged proteins in the base of ulcers or erosion, forming a physical barrier that restricts further caustic damage and stimulates mucosal prostaglandin and bicarbonate secretion. It may also bind epithelial growth factor and fibroblast growth factor, enhancing mucosalrepair a small amount of aluminum is absorbed, it should not be used for prolonged periods in patients with renal insufficiency. 1.bismuth subsalicylate, bismuth subcitrate and bismuth dinitrate are also available. 2. All bismuth formulations have an excellent safety profile. 3. Bismuth agents should be used for only short periods and should be avoided in patients with renal insufficiency. Opioid

文档评论(0)

zhuwo + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档